Edgewell Pers Care Co Financials
Edgewell Pers Care Co (EPC) reported $2.2B in revenue for fiscal year 2025, down 1.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Stable product economics are being overwhelmed by below-gross-profit cost pressure and increasingly uneven working-capital cash flow.
From FY2023 to FY2025, operating cash flow moved from-$216.1M to$118.4M , even as reported earnings weakened rather than recovered. With inventory dropping from$492.4M to$433.8M , that rebound looks more like working-capital release than a durable improvement in the business's earning power.
Revenue stayed near
FY2025 free cash flow recovered to
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Edgewell Pers Care Co's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Edgewell Pers Care Co has an operating margin of 4.3%, meaning the company retains $4 of operating profit per $100 of revenue. This results in a moderate score of 63/100, indicating healthy but not exceptional operating efficiency. This is down from 8.8% the prior year.
Edgewell Pers Care Co's revenue declined 1.3% year-over-year, from $2.3B to $2.2B. This contraction results in a growth score of 29/100.
Edgewell Pers Care Co has elevated debt relative to equity (D/E of 0.89), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 8/100, reflecting increased financial risk.
Edgewell Pers Care Co's current ratio of 1.76 indicates adequate short-term liquidity, earning a score of 51/100. The company can meet its near-term obligations, though with limited headroom.
Edgewell Pers Care Co's free cash flow margin of 1.9% results in a low score of 19/100. Capital expenditures of $77.0M absorb a large share of operating cash flow.
Edgewell Pers Care Co's ROE of 1.6% shows moderate profitability relative to equity, earning a score of 57/100. This is down from 6.2% the prior year.
Edgewell Pers Care Co scores 1.58, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Edgewell Pers Care Co passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Edgewell Pers Care Co generates $4.66 in operating cash flow ($118.4M OCF vs $25.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Edgewell Pers Care Co earns $1.32 in operating income for every $1 of interest expense ($96.6M vs $73.2M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Edgewell Pers Care Co generated $2.2B in revenue in fiscal year 2025. This represents a decrease of 1.3% from the prior year.
Edgewell Pers Care Co's EBITDA was $185.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 35.5% from the prior year.
Edgewell Pers Care Co reported $25.4M in net income in fiscal year 2025. This represents a decrease of 74.2% from the prior year.
Edgewell Pers Care Co earned $0.53 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 73.1% from the prior year.
Cash & Balance Sheet
Edgewell Pers Care Co generated $41.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 114.4% from the prior year.
Edgewell Pers Care Co held $225.7M in cash against $1.4B in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Edgewell Pers Care Co's gross margin was 41.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.8 percentage points from the prior year.
Edgewell Pers Care Co's operating margin was 4.3% in fiscal year 2025, reflecting core business profitability. This is down 4.5 percentage points from the prior year.
Edgewell Pers Care Co's net profit margin was 1.1% in fiscal year 2025, showing the share of revenue converted to profit. This is down 3.2 percentage points from the prior year.
Edgewell Pers Care Co's ROE was 1.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 4.6 percentage points from the prior year.
Capital Allocation
Edgewell Pers Care Co invested $57.6M in research and development in fiscal year 2025. This represents a decrease of 1.4% from the prior year.
Edgewell Pers Care Co spent $90.2M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 54.2% from the prior year.
Edgewell Pers Care Co invested $77.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 36.3% from the prior year.
EPC Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.2B | $2.2B-1.3% | $2.3B+0.1% | $2.3B+3.7% | $2.2B+4.0% | $2.1B+7.1% | $1.9B-8.9% | $2.1B-4.2% | $2.2B-2.8% | $2.3B-2.7% | $2.4B-2.4% | $2.4B-7.3% | $2.6B+6.7% | $2.4B-46.4% | $4.6B-1.7% | $4.6B |
| Cost of Revenue | $1.4B | $1.3B0.0% | $1.3B-1.0% | $1.3B+1.5% | $1.3B+13.7% | $1.1B+6.3% | $1.1B-9.0% | $1.2B-2.3% | $1.2B+2.5% | $1.2B-2.5% | $1.2B-2.9% | $1.2B-6.4% | $1.3B+5.8% | $1.2B-48.6% | $2.4B-2.8% | $2.5B |
| Gross Profit | $885.8M | $924.9M-3.2% | $955.7M+1.6% | $940.8M+6.8% | $880.5M-7.4% | $951.2M+8.0% | $880.9M-8.9% | $966.6M-6.4% | $1.0B-8.3% | $1.1B-2.9% | $1.2B-2.0% | $1.2B-8.2% | $1.3B+7.5% | $1.2B-43.9% | $2.1B-0.4% | $2.1B |
| R&D Expenses | $59.3M | $57.6M-1.4% | $58.4M-0.2% | $58.5M+5.4% | $55.5M-4.0% | $57.8M+4.5% | $55.3M+3.4% | $53.5M-12.4% | $61.1M-9.6% | $67.6M-6.0% | $71.9M+1.3% | $71.0M+2.2% | $69.5M+0.3% | $69.3M-38.4% | $112.5M+3.9% | $108.3M |
| SG&A Expenses | $443.6M | $425.0M-1.2% | $430.1M+5.0% | $409.6M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $17.8M | $96.6M-51.5% | $199.3M-12.2% | $227.0M+24.5% | $182.3M-24.0% | $239.9M+36.3% | $176.0M-27.8% | $243.8M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | $68.7M | $73.2M-4.3% | $76.5M-2.5% | $78.5M+9.9% | $71.4M+5.2% | $67.9M+10.9% | $61.2M-2.2% | $62.6M-7.9% | $68.0M-1.7% | $69.2M-3.6% | $71.8M-28.1% | $99.8M-16.1% | $119.0M-6.0% | $126.6M-0.5% | $127.3M+4.9% | $121.4M |
| Income Tax | -$14.9M | -$1.8M-108.1% | $22.3M-32.4% | $33.0M+34.1% | $24.6M-16.0% | $29.3M+48.7% | $19.7M+208.8% | -$18.1M-129.9% | $60.5M+203.2% | -$58.6M-242.2% | $41.2M+125.3% | -$162.6M-678.6% | $28.1M-44.0% | $50.2M-67.9% | $156.5M+8.1% | $144.8M |
| Net Income | -$93.2M | $25.4M-74.2% | $98.6M-14.0% | $114.7M+15.3% | $99.5M-15.5% | $117.8M+74.3% | $67.6M+118.2% | -$372.2M-460.3% | $103.3M+1712.3% | $5.7M-96.8% | $178.7M+164.9% | -$275.3M-177.3% | $356.1M-12.5% | $407.0M-0.5% | $408.9M+56.5% | $261.2M |
| EPS (Diluted) | — | $0.53-73.1% | $1.97-10.9% | $2.21+19.5% | $1.85-13.1% | $2.13+71.8% | $1.24+118.0% | -$6.88-462.1% | $1.90+1800.0% | $0.10-96.7% | $2.99+167.3% | -$4.44-178.0% | $5.69-12.1% | $6.47+4.0% | $6.22+67.2% | $3.72 |
TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
EPC Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.8B+0.7% | $3.7B-0.3% | $3.7B+0.7% | $3.7B+1.0% | $3.7B+3.8% | $3.5B+3.5% | $3.4B-13.5% | $4.0B-5.6% | $4.2B-12.2% | $4.8B-4.3% | $5.0B-28.0% | $6.9B+3.1% | $6.7B-0.2% | $6.7B+3.1% | $6.5B |
| Current Assets | $995.5M+6.4% | $936.0M-2.7% | $962.4M+2.1% | $942.2M-17.0% | $1.1B+15.5% | $983.6M-5.8% | $1.0B+9.8% | $951.2M-19.8% | $1.2B-18.3% | $1.5B-11.3% | $1.6B-40.0% | $2.7B+6.3% | $2.6B+1.8% | $2.5B+11.6% | $2.3B |
| Cash & Equivalents | $225.7M+7.9% | $209.1M-3.4% | $216.4M+14.7% | $188.7M-60.6% | $479.2M+31.4% | $364.7M+6.8% | $341.6M+28.2% | $266.4M-47.0% | $502.9M-31.9% | $738.9M+3.8% | $712.1M-36.9% | $1.1B+13.1% | $998.3M+38.9% | $718.5M+52.5% | $471.2M |
| Inventory | $433.8M-9.1% | $477.3M-3.1% | $492.4M+9.6% | $449.3M+30.0% | $345.7M+10.1% | $314.1M-12.1% | $357.2M+8.4% | $329.5M-1.2% | $333.5M+7.9% | $309.2M-7.1% | $332.8M-46.1% | $616.9M+0.1% | $616.3M-8.3% | $672.4M+2.9% | $653.4M |
| Accounts Receivable | $137.8M+26.0% | $109.4M+3.0% | $106.2M-22.4% | $136.9M-9.2% | $150.7M-5.1% | $158.8M-22.8% | $205.6M-9.2% | $226.5M+1.1% | $224.1M-14.0% | $260.7M-6.8% | $279.8M-43.5% | $495.0M+3.0% | $480.6M-29.0% | $676.7M-4.7% | $709.8M |
| Goodwill | $1.1B-15.1% | $1.3B+0.5% | $1.3B+0.7% | $1.3B+13.7% | $1.2B+0.3% | $1.2B+12.3% | $1.0B-28.8% | $1.5B+0.3% | $1.4B+1.8% | $1.4B-0.1% | $1.4B-4.4% | $1.5B+0.8% | $1.5B+0.4% | $1.5B-0.4% | $1.5B |
| Total Liabilities | $2.2B+2.6% | $2.1B-2.4% | $2.2B-2.0% | $2.2B+7.4% | $2.1B-0.8% | $2.1B-0.4% | $2.1B-4.1% | $2.2B-9.7% | $2.4B-16.8% | $2.9B-5.8% | $3.1B-29.1% | $4.4B+3.3% | $4.3B-8.5% | $4.7B+5.2% | $4.4B |
| Current Liabilities | $565.5M+0.3% | $563.6M+7.7% | $523.4M-3.0% | $539.5M+0.5% | $536.8M+5.2% | $510.5M-22.6% | $659.6M-8.0% | $717.0M+36.7% | $524.4M-39.6% | $868.2M+30.2% | $666.8M-57.6% | $1.6B+36.4% | $1.2B-11.8% | $1.3B+27.3% | $1.0B |
| Long-Term Debt | $1.4B+8.5% | $1.3B-6.3% | $1.4B-2.2% | $1.4B+12.7% | $1.2B-0.3% | $1.2B+12.8% | $1.1B-0.5% | $1.1B-27.6% | $1.5B-1.2% | $1.5B-9.1% | $1.7B-4.0% | $1.8B-11.5% | $2.0B-6.5% | $2.1B-3.1% | $2.2B |
| Total Equity | $1.6B-2.0% | $1.6B+2.8% | $1.5B+5.0% | $1.5B-7.8% | $1.6B+10.6% | $1.4B+10.4% | $1.3B-25.3% | $1.7B+0.2% | $1.7B-4.8% | $1.8B-1.9% | $1.9B-26.1% | $2.5B+2.8% | $2.5B+18.6% | $2.1B-1.5% | $2.1B |
| Retained Earnings | $1.1B-0.3% | $1.1B+6.7% | $1.0B+8.8% | $939.1M+8.5% | $865.7M+10.6% | $782.4M+9.5% | $714.8M-34.0% | $1.1B+13.7% | $952.9M+0.7% | $946.0M+22.4% | $772.9M-43.7% | $1.4B+20.0% | $1.1B-61.8% | $3.0B+14.6% | $2.6B |
EPC Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $121.2M | $118.4M+151.3% | -$231.0M-6.9% | -$216.1M-311.9% | $102.0M-55.5% | $229.0M-1.5% | $232.6M+22.0% | $190.6M-26.5% | $259.4M-17.3% | $313.6M+67.9% | $186.8M+25.5% | $148.8M-74.0% | $572.0M-23.7% | $750.0M+18.7% | $631.6M+53.1% | $412.5M |
| Capital Expenditures | $68.8M | $77.0M+36.3% | $56.5M+14.1% | $49.5M-12.2% | $56.4M-0.7% | $56.8M+19.1% | $47.7M-17.8% | $58.0M-6.5% | $62.0M-10.1% | $69.0M-0.7% | $69.5M-30.1% | $99.4M+16.5% | $85.3M-5.8% | $90.6M-18.4% | $111.0M+13.3% | $98.0M |
| Free Cash Flow | $52.4M | $41.4M+114.4% | -$287.5M-8.2% | -$265.6M-682.5% | $45.6M-73.5% | $172.2M-6.9% | $184.9M+39.4% | $132.6M-32.8% | $197.4M-19.3% | $244.6M+108.5% | $117.3M+137.4% | $49.4M-89.9% | $486.7M-26.2% | $659.4M+26.7% | $520.6M+65.5% | $314.5M |
| Investing Cash Flow | $273.4M | -$72.9M-16.8% | -$62.4M-23.6% | -$50.5M+85.8% | -$355.4M-629.8% | -$48.7M+75.2% | -$196.4M-331.6% | -$45.5M+61.7% | -$118.8M-40.4% | -$84.6M-21.7% | -$69.5M+60.2% | -$174.8M+33.6% | -$263.4M-195.6% | -$89.1M+6.1% | -$94.9M+73.9% | -$363.5M |
| Financing Cash Flow | -$193.8M | -$30.0M+83.3% | -$179.4M-22.5% | -$146.5M-732.4% | -$17.6M+73.1% | -$65.4M-249.7% | -$18.7M+70.7% | -$63.8M+83.2% | -$379.6M+20.6% | -$478.0M-411.8% | -$93.4M+71.5% | -$327.2M-121.5% | -$147.7M+60.9% | -$377.5M-33.3% | -$283.3M-40.2% | -$202.0M |
| Dividends Paid | $28.4M | $29.3M-4.6% | $30.7M-2.5% | $31.5M-3.4% | $32.6M+27.3% | $25.6M | $0 | $0 | N/A | $0 | $0-100.0% | $93.2M-24.8% | $123.9M+17.3% | $105.6M+324.1% | $24.9M | $0 |
| Share Buybacks | $15.8M | $90.2M+54.2% | $58.5M-22.2% | $75.2M-40.0% | $125.3M+1262.0% | $9.2M | $0 | $0-100.0% | $124.4M-24.8% | $165.4M-15.9% | $196.6M+12.2% | $175.2M+85.6% | $94.4M | $0-100.0% | $417.8M+51.4% | $276.0M |
TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
EPC Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 41.6%-0.8pp | 42.4%+0.6pp | 41.8%+1.2pp | 40.5%-5.0pp | 45.6%+0.4pp | 45.2%0.0pp | 45.1%-1.1pp | 46.2%-2.8pp | 49.0%-0.1pp | 49.1%+0.2pp | 48.9%-0.5pp | 49.4%+0.4pp | 49.0%+2.2pp | 46.8%+0.6pp | 46.2% |
| Operating Margin | 4.3%-4.5pp | 8.8%-1.2pp | 10.1%+1.7pp | 8.4%-3.1pp | 11.5%+2.5pp | 9.0%-2.4pp | 11.4% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | 1.1%-3.2pp | 4.4%-0.7pp | 5.1%+0.5pp | 4.6%-1.1pp | 5.6%+2.2pp | 3.5%+20.9pp | -17.4%-22.0pp | 4.6%+4.4pp | 0.3%-7.3pp | 7.6%+18.9pp | -11.4%-25.0pp | 13.6%-3.0pp | 16.6%+7.7pp | 8.9%+3.3pp | 5.6% |
| Return on Equity | 1.6%-4.6pp | 6.2%-1.2pp | 7.4%+0.7pp | 6.8%-0.6pp | 7.4%+2.7pp | 4.7%+33.2pp | -28.5%-34.5pp | 5.9%+5.6pp | 0.3%-9.4pp | 9.8%+24.5pp | -14.8%-28.9pp | 14.1%-2.5pp | 16.6%-3.2pp | 19.8%+7.3pp | 12.4% |
| Return on Assets | 0.7%-2.0pp | 2.6%-0.4pp | 3.1%+0.4pp | 2.7%-0.5pp | 3.2%+1.3pp | 1.9%+12.8pp | -10.9%-13.5pp | 2.6%+2.5pp | 0.1%-3.6pp | 3.8%+9.3pp | -5.5%-10.7pp | 5.1%-0.9pp | 6.1%0.0pp | 6.1%+2.1pp | 4.0% |
| Current Ratio | 1.76+0.1x | 1.66-0.2x | 1.84+0.1x | 1.75-0.4x | 2.12+0.2x | 1.93+0.3x | 1.58+0.3x | 1.33-0.9x | 2.26+0.6x | 1.67-0.8x | 2.45+0.7x | 1.73-0.5x | 2.23+0.3x | 1.93-0.3x | 2.20 |
| Debt-to-Equity | 0.89+0.1x | 0.80-0.1x | 0.88-0.1x | 0.95+0.2x | 0.78-0.1x | 0.860.0x | 0.84+0.2x | 0.63-0.2x | 0.880.0x | 0.84-0.1x | 0.91+0.2x | 0.70-0.1x | 0.81-0.2x | 1.030.0x | 1.05 |
| FCF Margin | 1.9%+14.6pp | -12.8%-1.0pp | -11.8%-13.9pp | 2.1%-6.2pp | 8.3%-1.2pp | 9.5%+3.3pp | 6.2%-2.6pp | 8.8%-1.8pp | 10.6%+5.7pp | 5.0%+2.9pp | 2.0%-16.6pp | 18.6%-8.3pp | 26.9%+15.5pp | 11.4%+4.6pp | 6.8% |
Similar Companies
Where Edgewell Pers Care Co Ranks
Frequently Asked Questions
What is Edgewell Pers Care Co's annual revenue?
Edgewell Pers Care Co (EPC) reported $2.2B in total revenue for fiscal year 2025. This represents a -1.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Edgewell Pers Care Co's revenue growing?
Edgewell Pers Care Co (EPC) revenue declined by 1.3% year-over-year, from $2.3B to $2.2B in fiscal year 2025.
Is Edgewell Pers Care Co profitable?
Yes, Edgewell Pers Care Co (EPC) reported a net income of $25.4M in fiscal year 2025, with a net profit margin of 1.1%.
What is Edgewell Pers Care Co's EBITDA?
Edgewell Pers Care Co (EPC) had EBITDA of $185.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Edgewell Pers Care Co have?
As of fiscal year 2025, Edgewell Pers Care Co (EPC) had $225.7M in cash and equivalents against $1.4B in long-term debt.
What is Edgewell Pers Care Co's gross margin?
Edgewell Pers Care Co (EPC) had a gross margin of 41.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Edgewell Pers Care Co's operating margin?
Edgewell Pers Care Co (EPC) had an operating margin of 4.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Edgewell Pers Care Co's net profit margin?
Edgewell Pers Care Co (EPC) had a net profit margin of 1.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Edgewell Pers Care Co's return on equity (ROE)?
Edgewell Pers Care Co (EPC) has a return on equity of 1.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Edgewell Pers Care Co's free cash flow?
Edgewell Pers Care Co (EPC) generated $41.4M in free cash flow during fiscal year 2025. This represents a 114.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Edgewell Pers Care Co's operating cash flow?
Edgewell Pers Care Co (EPC) generated $118.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Edgewell Pers Care Co's total assets?
Edgewell Pers Care Co (EPC) had $3.8B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Edgewell Pers Care Co's capital expenditures?
Edgewell Pers Care Co (EPC) invested $77.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Edgewell Pers Care Co spend on research and development?
Edgewell Pers Care Co (EPC) invested $57.6M in research and development during fiscal year 2025.
What is Edgewell Pers Care Co's current ratio?
Edgewell Pers Care Co (EPC) had a current ratio of 1.76 as of fiscal year 2025, which is generally considered healthy.
What is Edgewell Pers Care Co's debt-to-equity ratio?
Edgewell Pers Care Co (EPC) had a debt-to-equity ratio of 0.89 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Edgewell Pers Care Co's return on assets (ROA)?
Edgewell Pers Care Co (EPC) had a return on assets of 0.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Edgewell Pers Care Co's Altman Z-Score?
Edgewell Pers Care Co (EPC) has an Altman Z-Score of 1.58, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Edgewell Pers Care Co's Piotroski F-Score?
Edgewell Pers Care Co (EPC) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Edgewell Pers Care Co's earnings high quality?
Edgewell Pers Care Co (EPC) has an earnings quality ratio of 4.66x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Edgewell Pers Care Co cover its interest payments?
Edgewell Pers Care Co (EPC) has an interest coverage ratio of 1.32x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Edgewell Pers Care Co?
Edgewell Pers Care Co (EPC) scores 38 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.